FDA/Customs automated import clearance system to be implemented nationwide by September.
FDA/CUSTOMS AUTOMATED IMPORT CLEARANCE SYSTEM TO BE IMPLEMENTED NATIONWIDE by the end of September, FDA predicts. The system, dubbed OASIS (Operations & Administration Support Import System), enables importers, U.S. Customs officials and FDA to communicate electronically to release imports of products regulated by the agency. FDA and Customs began using OASIS in Seattle, Philadelphia, New Orleans and Baltimore on Dec. 2. By the end of fiscal year 1997, FDA expects to have OASIS fully implemented at over 350 Customs checkpoints at ports, border crossings and airports throughout the country.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth